IDOR- Instituto D'or de pesquisa. Av. São Rafael

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Multiple myeloma

Running trials

• Active, not recruiting

  Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  NCT05243797· Phase 3· European Myeloma Network B.V.· Source